Kashaf Waqar and A. Zainab, “The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis”, J Pak Med Assoc, vol. 72, no. 11, pp. 2366–2367, Oct. 2022.